C4BPA, as a cofactor of soluble complement inhibitor factor I, can help non-small cell lung cancer cells escape the cytotoxic activity of the complement system and enhance the invasiveness of tumor cells (Okroj et al., 2008). The gene discussed is C4BPA; the disease is neoplasm.